STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

May 31, 2023

Equity [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive loss (in thousands):

	Three Months Ended
	May 31,
	2023		2022
Cost of revenues	$	35	$	55
Research and development		372		764
Selling and marketing		639		560
General and administrative		1,132		1,581
	$	2,178	$	2,960

Summary of Stock Option Activity

Changes in our outstanding stock options during the three months ended May 31, 2023 were as follows (options in thousands):

	Number of Options			Weighted Average Exercise Price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at February 28, 2023		506		$	16.02		4.0
Granted		—			—
Exercised		—			—
Forfeited or expired		(506	)		16.02
Outstanding at May 31, 2023		-		$	-			$	-
Exercisable at May 31, 2023		-		$	-			$	-

Summary of Restricted Stock Shares (RSU's), and Performance Stock Units (PSU's) Activity

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the three months ended May 31, 2023 were as follows (restricted shares, PSUs and RSUs in thousands):

	Number of Restricted Shares, PSUs and RSUs			Weighted Average Grant Date Fair Value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Outstanding at February 28, 2023		3,506		$	6.75
Granted		-			-
Vested		(246	)		8.19		99,648
Forfeited		(291	)		6.17
Outstanding at May 31, 2023		2,969		$	6.69